Drugs / Lu AF20513
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03819699 | Dec 2018 → Jun 2019 | Alzheimer disease | H. Lundbeck A/S | Terminated | No outcome recorded |
| Phase 1 | NCT03668405 | Jun 2018 → May 2019 | Alzheimer disease | H. Lundbeck A/S | Terminated | No outcome recorded |
| Phase 1 | NCT02388152 | Mar 2015 → Jul 2019 | Alzheimer disease | H. Lundbeck A/S | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF20513 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03668405 ↗ |